Capital Bancorp 3Q26: Core EPS $0.89, NIM 5.81%, $0.14 Dividend Declared
CBNK sits 58% above its 52-week low of $26.4.
Summary
Capital Bancorp reported 3Q26 core EPS of $0.89 (up 2.3% QoQ) on a 5.81% NIM and declared a $0.14 dividend. Results are now secondary to the pending $728.1M all-stock merger with Peoples Bancorp.
Key Events · Earnings and Guidance · CBNK
-
3Q26 Core EPS $0.89, GAAP $0.80
Core net income of $14.7M, or $0.89 per diluted share, rose 2.3% from 2Q26 and 23.6% year-over-year. GAAP net income of $13.1M ($0.80) fell 7.9% QoQ after $1.6M of merger-related expenses.
-
NIM Expands to 5.81%
Net interest margin rose 17 bps from 2Q26 to 5.81%, and core NIM rose 14 bps to 4.18%, driven by commercial bank loan growth. Gross loans grew $80.2M, or 10.2% annualized.
-
$0.14 Quarterly Dividend Declared
Board declared $0.14 per share payable November 25, 2026 to stockholders of record on November 9, 2026, up from $0.12 a year earlier.
-
Buyback Suspended Pending Merger
No shares were repurchased in 3Q26. $12.4M remains under the $15.0M authorization expiring December 31, 2026, but the company does not expect further repurchases while the Peoples transaction is pending.
Analysis · CBNK · Finance
Core earnings held up better than the headline. GAAP EPS fell 8.0% to $0.80 on $1.6M of merger costs, yet core EPS rose 2.3% to $0.89 and core ROTCE came in at 15.24%. The quarter's real story, however, is the pending $728.1M all-stock sale to Peoples Bancorp at an implied $43.75 per share, which caps how much the standalone numbers matter. Buyback activity is suspended, and the $12.4M left on the repurchase authorization will likely go unused. Loan growth of 10.2% annualized and a 17 bps NIM expansion support the franchise value being sold; the deposit decline is mostly seasonal Title-business DDA runoff plus one large customer relationship.
How filings like this one have moved
In the 30 days to Oct 26, 2026, 29.9% of the 1374 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CBNK was trading at $41.69 on NASDAQ in the Finance sector, with a market capitalization of approximately $679.1M. The 52-week trading range was $26.40 to $41.89. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.